Overview

**Jinan Asia-Pacific Pharmaceutical Co., Ltd.** Established in 1993, Jinan Asia-Pacific Pharmaceutical Co., Ltd. is a Sino-American joint venture and a high-tech enterprise based in Jinan. It is the first company in China to produce food-grade choline, with over 60% of its products exported. The company specializes in the production and sales of choline and betaine series products, with food-grade choline being the largest in terms of production and sales globally. The company has a strong focus on international trade, with branches and offices in the United States and Europe. The company adheres strictly to GMP, ISO9001, ISO22000, Kosher, and Halal quality systems in production and management, providing high-quality products and services to the infant formula, pharmaceutical, health supplement, and cosmetics industries. Asia-Pacific Pharmaceutical Natural Nutritional Foods Division is located at No. 8 Zitong Avenue, Tianqiao District, Jinan City, in the Sino-German Central South High-Tech Industrial Park. The project was initiated in July 2019 and launched in October 2021. It is the first company in China to produce choline series health foods, with sales channels covering major online platforms and offline mother and baby medicine chains. The company has facilities for solid dosage forms, soft capsules, oral liquids, and a laboratory. Production capacity includes 300 million tablets per year, 33.6 million sachets of granules per year, 300 million soft capsules, and 6 million bottles of oral liquids. In 2023, Asia-Pacific Pharmaceutical's revenue exceeded 100 million yuan. In 2023, the company invested 300 million yuan in the development of the “Jinan Asia-Pacific Pharmaceutical Co., Ltd. Nutrition and Health Products Comprehensive Development Project” on the banks of Chengbo Lake in Jiyang District, Jinan. The project, with a total construction area of 42,900 square meters, will include production workshops, warehouses, offices, power facilities, and other ancillary facilities. The project will feature two production lines for food-grade choline with a designed capacity of 4,000 tons, one production line for food-grade betaine (export) with a designed capacity of 3,000 tons, a plant for plant extracts, and a health and nutritional foods production line. The total investment is estimated at 304.3 million yuan, with the first phase expected to be completed and operational by the end of 2024.